Ameritas Investment Company’s GSK GSK Stock Holding History

Ameritas Investment Company’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$503K	Buy	10,527 +5,329	+103%	+$268K	0.02%	417
2021 Q2	$304K	Buy	5,198 +2,040	+65%	+$98K	0.01%	564
2021 Q1	$141K	Sell	3,158 -1,482	-32%	-$67.3K	0.01%	668
2020 Q4	$213K	Sell	4,640 -1,575	-25%	-$72.3K	0.04%	386
2020 Q3	$317K	Hold	6,215	–	–	0.1%	220
2020 Q2	$317K	Sell	6,215 -243	-4%	-$12.5K	0.09%	226
2020 Q1	$305K	Buy	6,458 +566	+10%	+$30.2K	0.05%	270
2019 Q4	$346K	Sell	5,892 -315	-5%	-$17.5K	0.07%	237
2019 Q3	$332K	Buy	6,207 +1,339	+28%	+$68.9K	0.07%	250
2019 Q2	$244K	Sell	4,868 -139	-3%	-$6.97K	0.12%	178
2019 Q1	$262K	Sell	5,007 -3,556	-42%	-$178K	0.05%	263
2018 Q4	$409K	Buy	+8,563	New	+$422K	0.09%	187

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ameritas Investment Company's GSK Position: Q3 2021 in Review

Ameritas Investment Company increased its GSK (GSK) stake by 103% in Q3 2021, buying an estimated $268K and bringing the position to 10,527 shares worth $503K. The position accounts for 0.02% of the portfolio, ranked #417.

Ameritas Investment Company first reported a position in GSK in Q4 2018 and has held it in 12 quarters since. 793 funds tracked by Wall St. Rank hold GSK as of Q3 2021.

Ameritas Investment Company held 10,527 shares of GSK worth $503K as of Q3 2021.
Ameritas Investment Company bought 5,329 GSK shares in Q3 2021, an estimated $268K.
GSK made up 0.02% of Ameritas Investment Company's portfolio in Q3 2021, its #417 holding.
Ameritas Investment Company first reported a position in GSK in Q4 2018 and has held it in 12 quarters since.
793 funds tracked by Wall St. Rank held GSK as of Q3 2021.

Based on Ameritas Investment Company's 13F filing for Q3 2021, filed 12 Nov 2021.